Tenax Therapeutics (TENX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Operating Expenses | 2,862 | 2,719 | 3,213 | 3,802 | 1,965 |
| Operating Income | -2,862 | -2,719 | -3,212 | -3,802 | -1,965 |
| Interest Expense | 2 | 3 | 0 | 0 | 0 |
| Other Income | 2 | 0 | 6 | 4 | 248 |
| Pre-tax Income | -2,861 | -2,721 | -3,206 | -3,799 | -1,717 |
| Net Income Continuous | -2,861 | -2,721 | -3,206 | -3,799 | -1,717 |
| Net Income | $-2,861 | $-2,722 | $-3,211 | $-3,799 | $-1,717 |
| EPS Basic Total Ops | -181.60 | -172.80 | 499.20 | -240.00 | -160.00 |
| EPS Basic Continuous Ops | -181.65 | -172.76 | 494.25 | -241.17 | -159.56 |
| EPS Diluted Total Ops | -181.60 | -172.80 | 499.20 | -240.00 | -160.00 |
| EPS Diluted Continuous Ops | -181.65 | -172.76 | 494.25 | -241.17 | -159.56 |
| EBITDA(a) | $-2,834 | $-2,691 | $-3,186 | $-3,774 | $-1,936 |